Abdulaziz Al Oud, CFO ofSaudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO)
Saudi Pharmaceutical Industries and Medical Appliances Corp.’s (SPIMACO) CFO Abdulaziz Al Oud, said that the company’s share in the Kingdom’s pharmaceutical market reached 12.1% by the end of Q1 2025.
In an interview with Argaam, Al-Oud added that these figures reflect the continued improvement of SPIMACO’s competitive position in the market, emphasizing its leadership in the private sector within the Kingdom, based on the quality of its products, its diversity, and its operational efficiency.
He also pointed out that the positive results recorded during the first quarter reflect the successful implementation of the strategy aimed at boosting operational efficiency and achieving sustainable growth.
Abdulaziz Al Oud, CFO ofSaudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO)
Saudi Pharmaceutical Industries and Medical Appliances Corp.’s (SPIMACO) CFO Abdulaziz Al Oud, said that the company’s share in the Kingdom’s pharmaceutical market reached 12.1% by the end of Q1 2025.
In an interview with Argaam, Al-Oud added that these figures reflect the continued improvement of SPIMACO’s competitive position in the market, emphasizing its leadership in the private sector within the Kingdom, based on the quality of its products, its diversity, and its operational efficiency.
He also pointed out that the positive results recorded during the first quarter reflect the successful implementation of the strategy aimed at boosting operational efficiency and achieving sustainable growth.
